Malin Corporation | MLC - Ativos





Ativos Alterar Data
Akebia Therapeutics USD 376.56M 12.41M 2025-12
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
ALKERMES USD 2.49B 157.48M 2025-12
Avita Medical AUD 56.39M 1.74M 2025-12
Dianthus Therapeutics USD 530.92M 46.52M 2025-12
Eurofins Scientific SE EUR 10.99B 399.1M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
Lonza CHF 19.73B 1.85B 2024-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Moderna USD 12.34B 203M 2025-12
Organon & Co USD 13.55B 52M 2025-09
Ovoca Bio EUR 11.41M 3.36M 2022-06
Revvity USD 12.17B 29.46M 2025-12
Tectonic Therapeutic USD 277M 18.31M 2025-09
Viatris USD 37.19B 727.3M 2025-12
Xeris Pharmaceuticals USD 370.19M 35.5M 2025-09